Q9Y345 (SC6A5_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 113.
History...
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Sodium- and chloride-dependent glycine transporter 2 Short name=GlyT-2 Short name=GlyT2 Alternative name(s): Solute carrier family 6 member 5 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 797 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Terminates the action of glycine by its high affinity sodium-dependent reuptake into presynaptic terminals. May be responsible for the termination of neurotransmission at strychnine-sensitive glycinergic synapses. |
| Subcellular location | |
| Tissue specificity | Expressed in medulla, and to a lesser extent in spinal cord and cerebellum. |
| Involvement in disease | Hyperekplexia 3 (HKPX3) [MIM:614618]: A neurologic disorder characterized by neonatal hypertonia, an exaggerated startle response to tactile or acoustic stimuli, and life-threatening neonatal apnea episodes. Notably, in some cases, symptoms resolved in the first year of life. |
| Sequence similarities | Belongs to the sodium:neurotransmitter symporter (SNF) (TC 2.A.22) family. SLC6A5 subfamily. [View classification] |
Ontologies
| Keywords | |
|---|---|
| Biological process | Neurotransmitter transport Symport Transport |
| Cellular component | Membrane |
| Coding sequence diversity | Polymorphism |
| Disease | Disease mutation |
| Domain | Transmembrane Transmembrane helix |
| PTM | Glycoprotein |
| Technical term | Complete proteome Reference proteome |
| Gene Ontology (GO) | |
| Biological_process | synaptic transmission Traceable author statement Ref.1. Source: ProtInc |
| Cellular_component | integral to membrane Traceable author statement Ref.1. Source: ProtInc plasma membraneTraceable author statement. Source: Reactome |
| Molecular_function | glycine:sodium symporter activity Traceable author statement Ref.1. Source: ProtInc neurotransmitter:sodium symporter activityInferred from electronic annotation. Source: InterPro |
| Complete GO annotation... | |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||
Molecule processing | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 797 | 797 | Sodium- and chloride-dependent glycine transporter 2 | PRO_0000214762 | |||||
Regions | |||||||||
| Topological domain | 1 – 199 | 199 | Cytoplasmic Potential | ||||||
| Transmembrane | 200 – 220 | 21 | Helical; Name=1; Potential | ||||||
| Transmembrane | 228 – 247 | 20 | Helical; Name=2; Potential | ||||||
| Transmembrane | 271 – 291 | 21 | Helical; Name=3; Potential | ||||||
| Topological domain | 292 – 393 | 102 | Extracellular Potential | ||||||
| Transmembrane | 394 – 412 | 19 | Helical; Name=4; Potential | ||||||
| Transmembrane | 421 – 438 | 18 | Helical; Name=5; Potential | ||||||
| Transmembrane | 474 – 491 | 18 | Helical; Name=6; Potential | ||||||
| Transmembrane | 503 – 524 | 22 | Helical; Name=7; Potential | ||||||
| Transmembrane | 557 – 576 | 20 | Helical; Name=8; Potential | ||||||
| Transmembrane | 604 – 622 | 19 | Helical; Name=9; Potential | ||||||
| Transmembrane | 638 – 658 | 21 | Helical; Name=10; Potential | ||||||
| Transmembrane | 679 – 698 | 20 | Helical; Name=11; Potential | ||||||
| Transmembrane | 717 – 735 | 19 | Helical; Name=12; Potential | ||||||
| Topological domain | 736 – 797 | 62 | Cytoplasmic Potential | ||||||
Amino acid modifications | |||||||||
| Glycosylation | 343 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 353 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 358 | 1 | N-linked (GlcNAc...) Potential | ||||||
| Glycosylation | 364 | 1 | N-linked (GlcNAc...) Potential | ||||||
Natural variations | |||||||||
| Natural variant | 89 | 1 | A → E No effect on subcellular location; no effect on glycine transport. Ref.7 | VAR_044163 | |||||
| Natural variant | 102 | 1 | G → S. Ref.2 Corresponds to variant rs1443547 [ dbSNP | Ensembl ]. | VAR_044164 | |||||
| Natural variant | 124 | 1 | F → S. Ref.1 Ref.2 Ref.3 Ref.4 Ref.6 Corresponds to variant rs1443548 [ dbSNP | Ensembl ]. | VAR_044165 | |||||
| Natural variant | 132 | 1 | A → G. Corresponds to variant rs34243519 [ dbSNP | Ensembl ]. | VAR_044166 | |||||
| Natural variant | 162 | 1 | A → G. Ref.1 Ref.2 Ref.3 Ref.4 Ref.6 Corresponds to variant rs1443549 [ dbSNP | Ensembl ]. | VAR_044167 | |||||
| Natural variant | 184 | 1 | Q → R. Ref.3 | VAR_011591 | |||||
| Natural variant | 306 | 1 | L → V in HKPX3; compound heterozygote with S-509; impairment of glycine transport when coexpressed with S-509 in vitro. Ref.7 | VAR_044168 | |||||
| Natural variant | 425 | 1 | T → M in HKPX3; no effect on subcellular location; impairs glycine transport. Ref.7 | VAR_044169 | |||||
| Natural variant | 457 | 1 | K → N. Corresponds to variant rs3740870 [ dbSNP | Ensembl ]. | VAR_044170 | |||||
| Natural variant | 463 | 1 | D → N. Ref.3 Corresponds to variant rs1805091 [ dbSNP | Ensembl ]. | VAR_011592 | |||||
| Natural variant | 482 | 1 | W → C in HKPX3; no effect on subcellular location; impairs glycine transport. Ref.7 | VAR_044171 | |||||
| Natural variant | 491 | 1 | Y → C in HKPX3; no effect on subcellular location; impairs glycine transport. Ref.7 | VAR_044172 | |||||
| Natural variant | 499 | 1 | Y → F. Corresponds to variant rs7944684 [ dbSNP | Ensembl ]. | VAR_044173 | |||||
| Natural variant | 509 | 1 | N → S in HKPX3; compound heterozygote with V-306; no effect on subcellular location; impairs glycine transport. Ref.7 | VAR_044174 | |||||
| Natural variant | 510 | 1 | S → R in HKPX3; results in the formation of large aggregates in the cytoplasm; impairs glycine transport. Ref.7 | VAR_044175 | |||||
| Natural variant | 632 | 1 | V → E in a breast cancer sample; somatic mutation. Ref.8 | VAR_036160 | |||||
| Natural variant | 751 | 1 | V → A. Ref.3 | VAR_011593 | |||||
| Natural variant | 767 | 1 | G → R. Corresponds to variant rs16906628 [ dbSNP | Ensembl ]. | VAR_044176 | |||||
Experimental info | |||||||||
| Sequence conflict | 24 | 1 | G → S in AAD27892. Ref.2 | ||||||
| Sequence conflict | 155 | 1 | S → G in AAD27892. Ref.2 | ||||||
| Sequence conflict | 188 | 1 | N → D in AAD27892. Ref.2 | ||||||
| Sequence conflict | 362 | 1 | Q → L in AAD27892. Ref.2 | ||||||
| Sequence conflict | 582 | 1 | T → S in AAD27892. Ref.2 | ||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localisation of the gene in the human genome." Morrow J.A., Collie I.T., Dunbar D.R., Walker G.B., Shahid M., Hill D.R. FEBS Lett. 439:334-340(1998) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS SER-124 AND GLY-162. |
| [2] | "Characterization of multiple forms of the human glycine transporter type-2." Gallagher M.J., Burgess L.H., Brunden K.R. Brain Res. Mol. Brain Res. 70:101-115(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS SER-102; SER-124 AND GLY-162. Tissue: Spinal cord. |
| [3] | "Cloning, functional characterisation and population analysis of a variant form of the human glycine type 2 transporter." Evans J., Herdon H., Cairns W., O'Brien E., Chapman C., Terrett J., Gloger I. FEBS Lett. 463:301-306(1999) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS SER-124; GLY-162; ARG-184; ASN-463 AND ALA-751. Tissue: Spinal cord. |
| [4] | "Cloning and expression of a human glycine transporter type II." Luyten W. Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [MRNA], VARIANTS SER-124 AND GLY-162. |
| [5] | "Human chromosome 11 DNA sequence and analysis including novel gene identification." Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K., Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G. Sakaki Y.Nature 440:497-500(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], VARIANTS SER-124 AND GLY-162. |
| [7] | "Mutations in the gene encoding GlyT2 (SLC6A5) define a presynaptic component of human startle disease." Rees M.I., Harvey K., Pearce B.R., Chung S.K., Duguid I.C., Thomas P., Beatty S., Graham G.E., Armstrong L., Shiang R., Abbott K.J., Zuberi S.M., Stephenson J.B., Owen M.J., Tijssen M.A., van den Maagdenberg A.M., Smart T.G., Supplisson S., Harvey R.J. Nat. Genet. 38:801-806(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS HKPX3 VAL-306; MET-425; CYS-482; CYS-491; SER-509 AND ARG-510, VARIANT GLU-89, CHARACTERIZATION OF VARIANTS HKPX3 VAL-306; MET-425; CYS-482; CYS-491; SER-509 AND ARG-510, CHARACTERIZATION OF VARIANT GLU-89. |
| [8] | "The consensus coding sequences of human breast and colorectal cancers." Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D., Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V. Velculescu V.E.Science 314:268-274(2006) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT [LARGE SCALE ANALYSIS] GLU-632. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |
|---|---|
| EMBL GenBank DDBJ | AF085412 mRNA. Translation: AAC95145.1. AF142501 mRNA. Translation: AAD27892.1. AF352733 mRNA. Translation: AAK29670.1. AF117999 mRNA. Translation: AAK12641.1. AC090707 Genomic DNA. No translation available. BC096319 mRNA. Translation: AAH96319.1. |
| IPI | IPI00003484. |
| RefSeq | NP_004202.2. NM_004211.3. |
| UniGene | Hs.136557. |
3D structure databases | |
| ProteinModelPortal | Q9Y345. |
| SMR | Q9Y345. Positions 191-713. |
| ModBase | Search... |
Protein-protein interaction databases | |
| STRING | 9606.ENSP00000298923. |
PTM databases | |
| PhosphoSite | Q9Y345. |
Polymorphism databases | |
| DMDM | 296452967. |
Proteomic databases | |
| PaxDb | Q9Y345. |
| PRIDE | Q9Y345. |
Protocols and materials databases | |
| StructuralBiologyKnowledgebase | Search... |
Genome annotation databases | |
| Ensembl | ENST00000525748; ENSP00000434364; ENSG00000165970. |
| GeneID | 9152. |
| KEGG | hsa:9152. |
| UCSC | uc001mqd.3. human. |
Organism-specific databases | |
| CTD | 9152. |
| GeneCards | GC11P020620. |
| H-InvDB | HIX0035860. |
| HGNC | HGNC:11051. SLC6A5. |
| HPA | HPA039476. |
| MIM | 604159. gene. 614618. phenotype. |
| neXtProt | NX_Q9Y345. |
| Orphanet | 3197. Hereditary hyperekplexia. |
| PharmGKB | PA35911. |
| GenAtlas | Search... |
Phylogenomic databases | |
| eggNOG | COG0733. |
| HOGENOM | HOG000116406. |
| HOVERGEN | HBG071421. |
| InParanoid | Q9Y345. |
| KO | K05038. |
| OMA | GNALHCK. |
| OrthoDB | EOG4HDST0. |
Enzyme and pathway databases | |
| Reactome | REACT_15518. Transmembrane transport of small molecules. REACT_20679. Amine compound SLC transporters. |
Gene expression databases | |
| Bgee | Q9Y345. |
| CleanEx | HS_NET1. HS_SLC6A5. |
| Genevestigator | Q9Y345. |
| GermOnline | ENSG00000165970. Homo sapiens. |
Family and domain databases | |
| InterPro | IPR000175. Na/ntran_symport. [Graphical view] |
| PANTHER | PTHR11616. PTHR11616. 1 hit. |
| Pfam | PF00209. SNF. 1 hit. [Graphical view] |
| PRINTS | PR00176. NANEUSMPORT. |
| PROSITE | PS00610. NA_NEUROTRAN_SYMP_1. 1 hit. PS00754. NA_NEUROTRAN_SYMP_2. 1 hit. PS50267. NA_NEUROTRAN_SYMP_3. 1 hit. [Graphical view] |
| ProtoNet | Search... |
Other | |
| BindingDB | Q9Y345. |
| ChEMBL | CHEMBL3060. |
| DrugBank | DB00145. Glycine. |
| GenomeRNAi | 9152. |
| NextBio | 34335. |
| SOURCE | Search... |
Entry information
| Entry name | SC6A5_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q9Y345 Secondary accession number(s): O95288, Q4VAM7, Q9BX77 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 11 Human chromosome 11: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| SIMILARITY comments Index of protein domains and families |

Clusters with
